1. Home
  2. CODX vs MIGI Comparison

CODX vs MIGI Comparison

Compare CODX & MIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • MIGI
  • Stock Information
  • Founded
  • CODX 2013
  • MIGI 2012
  • Country
  • CODX United States
  • MIGI United States
  • Employees
  • CODX N/A
  • MIGI N/A
  • Industry
  • CODX Medical/Dental Instruments
  • MIGI Finance: Consumer Services
  • Sector
  • CODX Health Care
  • MIGI Finance
  • Exchange
  • CODX Nasdaq
  • MIGI Nasdaq
  • Market Cap
  • CODX 9.8M
  • MIGI 10.1M
  • IPO Year
  • CODX 2017
  • MIGI N/A
  • Fundamental
  • Price
  • CODX $0.28
  • MIGI $0.42
  • Analyst Decision
  • CODX Buy
  • MIGI Hold
  • Analyst Count
  • CODX 2
  • MIGI 1
  • Target Price
  • CODX $5.50
  • MIGI N/A
  • AVG Volume (30 Days)
  • CODX 462.7K
  • MIGI 289.8K
  • Earning Date
  • CODX 08-07-2025
  • MIGI 08-18-2025
  • Dividend Yield
  • CODX N/A
  • MIGI N/A
  • EPS Growth
  • CODX N/A
  • MIGI N/A
  • EPS
  • CODX N/A
  • MIGI N/A
  • Revenue
  • CODX $3,497,583.00
  • MIGI $54,308,189.00
  • Revenue This Year
  • CODX N/A
  • MIGI N/A
  • Revenue Next Year
  • CODX $42.11
  • MIGI N/A
  • P/E Ratio
  • CODX N/A
  • MIGI N/A
  • Revenue Growth
  • CODX N/A
  • MIGI N/A
  • 52 Week Low
  • CODX $0.23
  • MIGI $0.35
  • 52 Week High
  • CODX $2.23
  • MIGI $2.45
  • Technical
  • Relative Strength Index (RSI)
  • CODX 43.19
  • MIGI 37.78
  • Support Level
  • CODX $0.26
  • MIGI $0.41
  • Resistance Level
  • CODX $0.29
  • MIGI $0.47
  • Average True Range (ATR)
  • CODX 0.02
  • MIGI 0.05
  • MACD
  • CODX 0.00
  • MIGI -0.01
  • Stochastic Oscillator
  • CODX 26.83
  • MIGI 10.53

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.

Share on Social Networks: